Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1469-1477

  Clarke, Patrick ^a   Mann, Jeffrey ^a   Simpson, Jean F ^a   Rickard Dickson, Karen ^a   Primus, F James ^a,b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; GENE SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, SOUTHERN; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; CELL DIVISION; COLONIC NEOPLASMS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY, ACTIVE; MICE; MICE, TRANSGENIC; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0032054727     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Boon, T., Cerottini, J-C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
2. Finn, O. Tumor-rejection antigens recognized by T lymphocytes. Curr. Opin. Immunol., 5; 701-708, 1993.
3. Houghton, A. N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med., 180: 1-4, 1994.
4. Livingston, P. O. Construction of cancer vaccines with carbohydrate and protein (peptide) tumor antigens. Curr. Opin. Immunol., 4: 624-629, 1992.
5. Mitchell, M. S., Harel, W., Kempf, R. A., Hu, E., Kan-Mitchell, J., Boswell, W. D., Dean, G., and Stevenson, L. Active-specific immunotherapy for melanoma. J. Clin. Oncol., 8: 856-869, 1990.
6. Nap, M., Mollgard, K., Burtin, P., and Fleuren, G. J. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus, and adult. Tumor Biol., 9: 145-153, 1988.
7. Wittekind, C. Carcinoembryonic antigen family members as diagnostic tools in immunohistopathology. Tumor Biol., 16: 42-47, 1995.
8. Matzku, S., Zöller. M., Schulz, U., Dietze, W., Barth, H. O., Saeger, H-D., and Price, M. R. Lack of correlation between carcinoembryonic antigen content of tumor extracts and leukocyte migration reactivity of tumor patients. J. Natl. Cancer Inst. (Bethesda), 64: 1345-1348, 1980.
9. Müller, M., Irmscher, J., Heidl, G., Grossmann, H., Wagner, H., Kotzsch, M., and Zotter, S. Sensitization of human lymphocytes to carcinoembryonic antigen (CEA): neutralization experiments with anti-CEA sera. Exp. Pathol., 21: 5-9, 1982.
10. Hill, R., Khoo, S. K., Daunter, B., Silburn, P. A., and Mackay, E. V. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma. Int. J. Cancer, 30: 587-592, 1982.
11. Lo Gerfo, P., Herter, F. P., and Bennet, S. J. Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies. Int. J. Cancer, 9: 344-348, 1972.
12. Gold, P. Circulating antibodies against carcinoembryonic antigens of the human digestive system. Cancer (Phila.), 20: 1663-1667, 1967.
13. Durrant, L. G., Denton, G. W. L., Jacobs, E., Mee, M., Moss, R., Austin, E. B., Baldwin, R. W., Hardcastle, J. D., and Robins, R. A. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. Int. J. Cancer, 50: 811-816, 1992.
14. Koda, J., Glass, M. C., and Chang, H. R. Generation of human monoclonal antibodies against colon cancer. Arch. Surg. 125: 1591-1597, 1990.
15. Foon, K. A., Chakraborty, M., John, W. J., Sherratt, A., Köhler, H., and Bhattacharya-Chatterjee, M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest., 96: 334-342, 1995.
16. Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M., and Schlom, J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl. Cancer Inst. (Bethesda), 87: 982-990, 1995.
17. Conry, R. M., Saleh, M. N., Schlom, J., and LoBuglio, A. F. Breaking tolerance to carcinoembryonic antigen with a recombinant vaccinia virus vaccine in man. Proc. Am. Assoc. Cancer Res., 36: 492, 1995.
18. McCuaig, K., Rosenberg, M., Nédellec, P., Turbide, C., and Beauchemin, N. Expression of the BGP gene and characterization of mouse colon biliary glycoprotein isoforms. Gene, 127: 173-183, 1993.
19. Schrewe, H., Thompson, J., Bona, M., Hefta, L. J. F., Maruya, A., Hassauer, M., Shively, J. E., von Kleist, S., and Zimmermann, W. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression, Mol. Cell. Biol., 10: 2738-2748, 1990.
20. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 9.16-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
21. Mann, J. R., and McMahon, A. P. Factors influencing production frequency of transgenic mice. Methods Enzymol. 225: 771-781, 1993.
22. Erlich, H. A. PCR Technology: Principles and Applications for DNA Amplification, p. 246. New York: Stockton Press, 1989.
23. Miklos, G. L. G., and Rubin, G. M. The role of the genome project in determining gene function: insights from model organisms. Cell, 86: 521-529, 1996.
24. Dinchuk, J. E., Kelley, K., and Boyle, A. L. Fluorescence in situ hybridization of interphase nuclei isolated from whole blood of transgenic mice. Biotechnology, 17: 954-959, 1994.
25. Esteban, J. M., Paxton, R., Mehta, P., Battifora, H., and Shively, J. E. Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues. Hum. Pathol., 24: 322-328, 1993.
26. Nap, M., Hammarström, M-L., Börmer, O., Hammarström, S., Wagener, C., Handt, S., Schreyer, M., Mach, J-P., Buchegger, F., von Kleist, S., Grunert, F., Sequin, P., Fuks, A., Holm, R., and Lamerz, R. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res., 52: 2329-2339, 1992.
27. Simpson, J. F., Primus, F. J., and Schlom, J. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein (TAG-72) in human colon adenocarcinomas. Int. J. Biol. Mark., 6: 83-90, 1991.
28. Neumaier, M., Shively, L., Chen, F-S., Gaida, F-J., Ilgen, C., Paxton, R. J., Shively, J. E., and Riggs, A. D. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res., 50: 2128-2134, 1990.
29. Rosenberg, S. A., Mulé, J. J., Spiess, P. J., Reichert, C. M., and Schwarz, S. L. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. J. Exp. Med., 161: 1169-1188, 1985.
30. Kuroki, M., Koga, Y., and Matsuoka, Y. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces. Cancer Res., 41: 713-720, 1981.
31. Eades-Pemer, A-M., van der Putten, H., Hirth, A., Thompson, J., Neumaier, M., von Kleist, S., and Zimmermann, W. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res., 54: 4169-4176, 1994.
32. Primus, F. J., Clark, C. A., and Goldenberg, D. M. Immunoperoxidase localization of carcinoembryonic antigen in normal human intestinal mucosa. J. Natl. Cancer Inst. (Bethesda), 67: 1031-1039, 1981.
33. Lisowska, E., Krop-Watorek, A., and Sedlaczek, P. The dimeric structure of carcinoembryonic antigen (CEA). Biochem. Biophys. Res. Commun., 115: 206-211, 1983.
34. Hefta, S. A., Hefta, L. J., Lee, T. D., Paxton, R. J., and Shively, J. E. Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site. Proc. Natl. Acad. Sci. USA, 85: 4648-4652, 1988.
35. Cross, G. A. M. Glycolipid anchoring of plasma membrane proteins. Annu. Rev. Cell Biol., 6: 1-39, 1990.
36. Hasegawa, T., Isobe, K., Tsuchiya, Y., Oikawa, S., Nakazato, H., Ikezawa, H., Nakashima, I., and Shimokata, K. Establishment and characterization of human carcinoembryonic antigen transgenic mice. Br. J. Cancer, 64: 710-714, 1991.
37. Hefta, L. J. F., Schrewe, H., Thompson, J. A., Oikawa, S., Nakazato, H., and Shively, J. E. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products. Cancer Res., 50: 2397-2403, 1990.
38. Matsui, T., Hamako, J., Kameyama, K-Z., Kurosawa, Y., Titani, K., and Mizuochi, T. The occurrence of mouse-type oligosaccharides in mouse-human chimeric immunoglobulin G. Biochem. Biophys. Res. Commun., 164: 245-250, 1989.
39. Primus, F. J., Bennett, S. J., Kim, E., DeLand, F. H., Zahn, M. C., and Goldenberg, D. M. Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res., 40: 497-501, 1980.
40. Ballesta, A. M., Molina, R., Filella, X., Jo, J., and Giménez, N. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumor Biol., 16: 32-41, 1995.
41. Corbett, T. H., Groswold, D. P., Roberts, B. J., Peckham, J. C., and Schabel, F. M. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res., 35: 2434-2439, 1975.
42. Pèlegrin, A., Terskikh, A., Hayoz, D., Chalandon, Y., Olsson, N-O., Folli, S., Buchegger, F., Kromer, B., Schwarz, K., Martin, M., Martin, F., and Mach, J-P. Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and and as rejection antigen in syngeneic rats. Int. J. Cancer, 52: 110-119, 1992.
43. Robbins, P. F., Kantor, J. A., Salgaller, M., Hand, P. H., Fernsten, P. D., and Schlom, J. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res., 51: 3657-3662, 1991.
44. Bei, R., Kantor, J., Kashmiri, S. V. S., Abrams, S., and Schlom, J. Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA) in ice primed with the recombinant vaccinia CEA. J. Immunother., 16: 275-282, 1994.
45. Conry, R. M., LoBuglio, A. F., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., and Curiel, D. T. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther., 2: 59-65, 1995.
46. Hodge, J. W., McLaughlin, J. P., Abrams, S. I., Shupert, W. L., Schlom, J., and Kantor, J. A. Admixture of a recombinant vaccinia containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res., 55: 3598-3603, 1995.
47. McLaughlin, J. P., Schlom, J., Kantor, J. A., and Greiner, J. W. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with inlerleukin 2. Cancer Res., 56: 2361-2367, 1996.
48. Pervin, S., Chakraborty, M., Bhattacharya-Chatterjee, M., Zeytin, H., Foon, K. A., and Chatterjee, S. K. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen. Cancer Res., 57: 728-734, 1997.
49. Hand, P. H., Robbins, P. F., Salgaller, M. L., Poole, D. J., and Schlom, J. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies. Cancer Immunol. Immunother., 36: 65-75, 1993.
50. Adelstein, S., Pritchard-Briscoe, H., Anderson, T. A., Crosbie, J., Gammon, G., Loblay, R. H., Basten, A., and Goodnow, C. C. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (Washington DC), 251: 1223-1225, 1991.
51. Clarke, P., Szalai, G., and Primus, F. J. A single gene-encoded antibody for targeting IL-2 to tumors. FASEB J., 10: A1350, 1996.
52. Bruno, R., Mach, J-P., Mani, J-C., Ychou, M., Folii, S., Artus, J-C., and Pèlegrin, A. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor α. Cancer Res., 56: 4758-4765, 1996.
53. Sikorska, H., Shuster, J., and Gold, P. Clinical application of carcinoembryonic antigen. Cancer Detect. Prev. 120: 321-355, 1988.